CCCC
C4 Therapeutics Inc.
Company Overview
| Mkt Cap | $224.90M | Price | $2.61 |
| Volume | 1.60M | Change | +6.10% |
| P/E Ratio | -2.1 | Open | $2.45 |
| Revenue | $35.6M | Prev Close | $2.46 |
| Net Income | $-105.3M | 52W Range | $1.09 - $6.52 |
| Div Yield | N/A | Target | $11.50 |
| Overall | 53 | Value | 60 |
| Quality | 42 | Technical | 58 |
No chart data available
Stock Overview
Updated DailyC4 Therapeutics Inc. (CCCC) is a leading Manufacturing company in the Biological Product (except Diagnostic) Manufacturing industry, currently trading at $2.61 with a market capitalization of $224.90 million. The stock is in the lower portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows CCCC with a volume of 1.60 million shares. The stock opened down 0.41% from yesterday's close of $2.46. Current analyst estimates project earnings of $-1.48 per share for this year, with next year targeting $-1.27.
CCCC demonstrates neutral technical outlook based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for CCCC include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 340.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 08:30 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CCCC | $2.61 | +6.1% | 1.60M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |